News

The Latest Industry News

Groundbreaking Ceremony at New Round Rock Office

Posted on January 27, 2017

Construction at our new Texas Diabetes & Endocrinology office in Round Rock has started. The new building will allow us to serve our patients better by integrating our weight loss program, our research department, and will expand our clinic space. Our patients will also appreciate the increased parking space. The new building will be at […]

Read More

Continuous Glucose Monitors (CGMs) – Gold Standard of Care for Adults with Type 1 Diabetes

Posted on November 18, 2016

The Endocrine Society recently issued a Clinical Practice Guideline recommending continuous glucose monitors (CGMs) as the gold standard of care for adults with Type 1 diabetes. Here at Texas Diabetes & Endocrinology, we provide comprehensive training and support for continuous glucose monitoring. The guideline, titled “Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring […]

Read More

Texas Diabetes & Endocrinology Partners with MyDiabetesHome

Posted on November 11, 2016

Texas Diabetes & Endocrinology is proud to announce our new partnership with MyDiabetesHome.  MyDiabetesHome.com is a personalized diabetes management platform providing diabetic patients with tools to track  blood sugar and manage medications. The interactive dashboard is easily accessible via computer, tablet or mobile device and allows patients to simplify their life, drastically improve doctor visits, […]

Read More

FDA approves first automated insulin-delivery device for type 1 diabetes

Posted on October 7, 2016

The FDA announced the approval of Medtronic’s MiniMed 670G, the first hybrid closed loop system – often referred to as an “artificial pancreas” – on September 28th. The device is designed to check sugar levels, and provide appropriate insulin doses, based on those readings. It is currently approved for use for people aged 14 years and […]

Read More

New Postmenopausal Osteoporosis Guidelines

Posted on September 30, 2016

The American Association of Clinical Endocrinologists (AACE) has updated its postmenopausal osteoporosis guidelines. The new guidelines cover risk factors and fall prevention measures in more detail than prior guidelines. Pharmacological treatment is recommended for patients with osteoporosis, patients with osteopenia who have had a fragility fracture of the hip or spine, and for patients with […]

Read More

Kerem Ozer, MD inducted as a Fellow of the American College of Endocrinology

Posted on July 26, 2016

The American College of Endocrinology (ACE), the educational and research arm of the American Association of Clinical Endocrinologists (AACE), inducted Dr. Kerem Ozer, Texas Diabetes & Endocrinology physician partner, as a Fellow of the American College of Endocrinology during its recent convocation ceremony at the 2016 AACE Annual Meeting and Clinical Congress in Orlando, Florida. […]

Read More

Statins & Diabetes

Posted on July 14, 2016

Despite great strides in health care, heart disease remains the number one cause of death in the United States. Individuals with diabetes are three times more likely to develop heart disease, heart attack or stroke than someone without diabetes. We at TDE take this very seriously and work with our patients to reduce their cardiac […]

Read More

Study published in JAMA Network by Lindsay Harrison, MD

Posted on June 13, 2016

Effect of Adding Liraglutide vs Placebo to a High-Dose lnsulin Regimen in Patients With Type 2 Diabetes: A Randomized Clinical Trial Liraglutide added to high-dose insulin therapy improved glycemic control, decreased body weight, and enhanced treatment satisfaction in this difficult-to-treat patient population with high-dose insulin requirements. Further studies are warranted to confirm these findings and […]

Read More

Benefits of Continuous Glucose Monitors (CGMs)

Posted on May 25, 2016

Achieving your target hemoglobin A1C when you have diabetes can be difficult, and even more so if you have a fear of hypoglycemia (low blood glucose), as many do. The natural reaction is to allow blood sugar levels to remain high in order to prevent low glucose episodes. However, in the long run, we know […]

Read More

First Pediatric Research Trial – Faster Acting Meal Time Insulin

Posted on May 3, 2016

READY. SET. GO!!! Texas Diabetes & Endocrinology (TDE) announced today they are scheduling for the first, of a series of several, pediatric/teen research trials. This first study will be researching an investigational faster acting meal time insulin in children ages 10 to 17 years of age who are currently on multiple daily injections of insulin. […]

Read More

Intensive Lifestyle Intervention Improves Metabolism and Bone Strength

Posted on April 19, 2016

Older adults with obesity and type 2 diabetes saw improved glucose control, body composition, physical function, and bone quality when assigned to an intensive diet and exercise program. Preliminary results from an ongoing trial at the Baylor College of Medicine in Houston were just presented at the Endocrine Society Annual Meeting in Boston. Investigators looked […]

Read More

First Pediatric Research Trial Begins May 1, 2016

Posted on April 1, 2016

Time to jump in!!! On May 1st, Texas Diabetes & Endocrinology will be initiating the first, of a series of several, pediatric/teen research trials. This first study will be researching an investigational faster acting meal time insulin in children ages 10 to 17 years of age who are currently on multiple daily injections of insulin. […]

Read More

Lindsay Harrison, MD authors study published in the Journal of Clinical Endocrinology & Metabolism

Posted on March 11, 2016

Texas Diabetes & Endocrinology physician Lindsay Harrison, MD authored a study that was recently published in the JCEM titled Mechanisms of Action of Liraglutide in Patients with Type 2 Diabetes Treated with High Dose Insulin. The study concluded that Treatment with liraglutide significantly improved insulin secretion even in patients with long-standing T2D requiring high-dose insulin […]

Read More

Texas Diabetes & Endocrinology Founder Thomas Blevins, MD Moderates Expert Assembly and Serves on Writing Committee

Posted on February 26, 2016

Expert Assembly Spearheaded by American Association of Clinical Endocrinologists Calls for Expanded Use of Continuous Glucose Monitoring Technology in the Care of People With Diabetes WASHINGTON, D.C. – (February 23, 2016) – A consensus conference convened by the American Association of Clinical Endocrinologists (AACE) this past weekend advocated for expanded use of continuous glucose monitoring […]

Read More

Texas Diabetes & Endocrinology Proudly Offers a Physician-supervised Weight Loss Program

Posted on February 11, 2016

According to a recent Johns Hopkins University study featured on Good Morning America, some weight loss centers don’t follow medical guidelines. At Texas Diabetes & Endocrinology, the doctors, physician extenders and staff are committed to helping our patients lose weight, maintain weight loss and gain better control of their health. Our programs are medically supervised for […]

Read More

Pediatric Research Trials

Posted on January 26, 2016

Texas Diabetes & Endocrinology (TDE) is continuing forward in the effort to make available research for the children and teens of Austin, TX. The first wave will include a study for Type 1 diabetic children who are currently using daily injections of basal and mealtime insulin and have been for the last 6 months. The […]

Read More

Pediatric Diabetes Research

Posted on January 19, 2016

Parents will be pleased to know that beginning in February, Texas Diabetes & Endocrinology (TDE) will begin clinical trials for new insulins in children and teens with Type 1 diabetes. Dr. Tom Blevins, Medical Director of TDE Research explains, “We are excited to finally offer these trials to children and teens with Type 1 diabetes […]

Read More

Ideal Protein Dieter of the Week!

Posted on January 5, 2016

At Texas Diabetes & Endocrinology, the doctors, physician extenders and staff are committed to helping our patients lose weight, maintain weight loss and gain better control of their health. Obesity and carrying excess weight are increasingly common, which can lead to high blood pressure, elevated cholesterol, Diabetes as well as other health conditions. People with […]

Read More

Polycystic ovary syndrome (PCOS)

Posted on December 11, 2015

Polycystic ovary syndrome (PCOS) is an important cause of menstrual irregularity and androgen excess (elevations in testosterone) in women. It is one of the most common endocrine disorders affecting up to 8% of women overall.  Symptoms often include irregular menstrual cycles, facial hair, thinning hair on the scalp, acne and infertility.   Affected women also tend […]

Read More

Thyroid Nodules Are Common

Posted on December 4, 2015

Depending on the reference about 7% of incidentally noted thyroid nodules are found to be from thyroid cancer. The increase in imaging procedures (MRI, CT scans, neck ultrasounds) are finding many “incidental” thyroid nodules that we might not have otherwise detected on the physical exam. The vast majority of thyroid nodules are benign, however, the […]

Read More

American Thyroid Association Releases New Guidelines

Posted on November 27, 2015

The American Thyroid Association released their new Guidelines for managing thyroid nodules and differentiated thyroid cancer. The long-awaited guidelines incorporate new findings from a wide range of studies into 101 recommendations. Main areas that have seen major updates include role of molecular markers in diagnosis, imaging frequency for follow-up, indications for I-131 treatment, risk assessment […]

Read More

New Tools Calculate Absolute Risk for Blindness, Amputation in Adults with Diabetes

Posted on November 20, 2015

According to research in The BMJ, two new algorithms can accurately calculate the absolute risk during a 10-year period for developing blindness or needing limb amputation, two potentially serious complications for men and women living with type 1 or type 2 diabetes. The risk calculator takes into account multiple factors including age, type and duration […]

Read More

Insulin Degludec Now FDA-Approved for Type 1 and Type 2 Diabetes

Posted on November 13, 2015

On September 25th, the FDA approved Tresiba (insulin degludec / Novo Nordisk), making it the first new basal insulin to be approved in ten years. This is a once-daily, long acting basal insulin. The half-life is 25 hrs and it is active for up to 42 hours. One benefit of Tresiba is that the patient is […]

Read More

“Eat Well, America!”

Posted on November 6, 2015

November is American Diabetes Month and this years them is “Eat Well, America!” As the American Diabetes Association® celebrates its 75th anniversary, they want to share a timeless message—that eating well is one of life’s greatest pleasures, and enjoying delicious, healthy food helps with diabetes management. This November, the Association will show our nation how […]

Read More

Endocrine Society Releases New Interactive Guide to the Endocrine System

Posted on November 6, 2015

The guide, “Journey Through the Endocrine System”, uses 3-D animation to provide an overview of all endocrine-related organs and their function. A mobile app version will be released in early 2016. The guide is available here: http://www.hormone.org/hormones-and-health/the-endocrine-system.

Read More

Advancements in Insulin Therapy

Posted on October 8, 2015

This is an exciting time in Diabetes management as there are several advancements in insulin therapy available now and coming in the near future.  These therapies will provide patients with Type 1 and Type 2 diabetes with safer and more effective treatment options moving forward.  There are three therapies that we’re discussing here. Toujeo® (Insulin […]

Read More

Testosterone Deficiency and Aveed

Posted on September 30, 2015

Testosterone levels are checked in men at an increased frequency and more men are being prescribed testosterone replacement therapy than ever before.  Typical symptoms of low testosterone include fatigue, erectile dysfunction, low libido, and loss of muscle mass. As Endocrinologists, we try to find the underlying reason for the testosterone deficiency (or Hypogonadism) prior to […]

Read More

The Importance of Sleep for Metabolism

Posted on September 23, 2015

Why does your endocrinologist ask you how your sleep has been? One night of sleep loss can influence several genes in the body, that can lead to metabolic effects. According to a study recently published in the Journal of Clinical Endocrinology and Metabolism, these metabolic effects can include insulin resistance and weight gain. This was […]

Read More